Invasive candidiasis in the critically ill non-neutropenic patient
A García de Lorenzo y Mateos
|
1
|
Importance of invasive candidiasis in critical non-neutropenic patients
JC Montejo & A del Palacio
|
2-3
|
Traditional microbiological diagnosis for invasive candidiasis in critical non-neutropenic patients
MS Cuétara, A Alhambra & A del Palacio
|
4-7
|
Clinical spectrum of invasive candidiasis in critically ill non-neutropenic patients
M Sánchez García
|
8-11
|
Epidemiology of candidemia in ICU
B Galván & F Mariscal
|
12-15
|
Ophthalmoscopic examination in critically ill nonneutropenic patients: Candida endophthalmitis
E Pérez Blázquez
|
16-19
|
Microbiological non-culture methods for the diagnosis of invasive candidiasis: usefulness of surrogate markers
J Pontón
|
20-25
|
Molecular biology in the diagnosis of deep-seated candidiasis in the critically ill non-neutropenic patient
MF Colom, A Jover & C Ferrer
|
26-28
|
Risk factors in invasive candidiasis: stratification
A del Palacio, A Alhambra & MS Cuétara
|
29-31
|
Prevention of invasive candidiasis in the critically ill non neutropenic patient
JC Montejo, M Catalán & A del Palacio
|
32-34
|
Management strategies: prophylaxis, empirical and pre-emptive treatment and treatment of established invasive candidiasis in the critically ill non-neutropenic patient
A del Palacio, A Alhambra y MS Cuétara
|
35-38
|
Systemic antifungals. Pharmacodynamia and pharmacokinetics
M Catalán & JC Montejo
|
39-49
|
Antibodies to Candida albicans germ tubes in two intensive care patients with invasive candidiasis
JR Iruretagoyena, P Regúlez, G Quindós & J Pontón
|
50-53
|